Effectiveness of Oral Hydration in Preventing Contrast-Induced Nephropathy in Individuals Undergoing Elective Coronary Interventions.

Mariana Rodrigues Pioli, Renata Muller Couto, José de Arimatéia Francisco, Diego Quilles Antoniassi, Célia Regina de Souza, Matheus Ynada de Olivio, Gabriel Forato Anhê, Silvio Giopatto, Andrei C Sposito, Wilson Nadruz, Otavio Rizzi Coelho-Filho, Rodrigo Modolo

Journal: Arquivos brasileiros de cardiologia 2023;120(2):e20220529

PMID: 36856244

Abstract

BACKGROUND

Contrast-induced nephropathy (CIN) is defined as worsening renal function, represented by an increase in serum creatinine of ≥ 25% or ≥ 0.5 mg/dL up to 72 h after exposure to iodinated contrast medium (ICM). The most effective preventive measure to date is intravenous hydration (IVH). Little is known about the effectiveness of outpatient oral hydration (OH).

OBJETIVE

To investigate whether outpatient OH with water is as effective as IVH with 0.9% saline solution in preventing CIN in elective coronary procedures.

METHODS

In this retrospective observational study, we analyzed the medical records and laboratory data of individuals undergoing percutaneous coronary procedures with ICM. Data collected between 2012 and 2015 refer to individuals who underwent IVH and those collected between 2016 and 2020 (after implementation of an OH protocol) correspond to individuals who underwent OH at home before and after coronary procedures as instructed by the nursing team. Statistical significance was established at α = 0.05.

RESULTS

In total, 116 patients were included in this study: 58 in the IVH group and 58 in the OH group. An incidence of CIN of 15% (9/58) was observed in the group that received IVH and an incidence of 12% (7/58) was seen in the group that received OH (p = 0.68).

CONCLUSION

The OH protocol, performed by the patient, appears to be as effective as the in-hospital IVH protocol for the renal protection of individuals susceptible to CIN in elective coronary interventions. These findings should be put to test in larger trials.

Address: Universidade Estadual de Campinas Faculdade de Ciências Médicas - Departamento de Medicina Translacional, Programa de Farmacologia, Campinas, SP - Brasil.; Universidade Estadual de Campinas Faculdade de Ciências Médicas - Departamento de Medicina Interna - Divisão de Cardiologia, Campinas, SP - Brasil.; Universidade Estadual de Campinas (UNICAMP) - Laboratório de Aterosclerose e Biologia Vascular (Atherolab), Campinas, SP - Brasil.; Universidade Estadual de Campinas (UNICAMP) - Disciplina de Cardiologia, Campinas, SP - Brasil.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.